EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

DrugRepur AI: An Explainable Knowledge Graph Embedding Platform for Drug Repurposing with Multi-Level Biological Validation

Momin Mohammad Fuzail, Barrawaz Aateka Yahya, Shaikh Shoaib Iftekhar, Sarfaraz Khan

Journal of Innovations in Pharmaceutical and Biological Sciences · 2026 · 13 (01) · 67-75

DOI: 10.56511/jipbs.2026.13108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Innovations in Pharmaceutical and Biological Sciences, 2026. Verfasst von Momin Mohammad Fuzail und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Most computational drug repurposing systems generate predictions without providing mechanistic justification, biological context, or clinical evidence. This disconnect between prediction and understanding limits practical adoption by pharmaceutical researchers.

Objective

To design and validate an integrated platform combining knowledge graph embedding-based prediction with multi-level biological validation for drug repurposing hypothesis generation.

Methods

A RotatE knowledge graph embedding model was trained on a DrugBank-derived knowledge graph containing 16,698 entities and 2.94 million relational triples using PyKEEN. The prediction engine was wrapped in a validation architecture comprising dual-tiered explainability (path-based and embedding-based reasoning), disease pathway analysis, drug target identification with druggability scoring, biomarker discovery via transcriptomic reversal analysis, chemical similarity search, ClinicalTrials.gov integration, literature mining, pharmacovigilance-based safety profiling, and novelty assessment.

Results

Internal validation against RepoDB yielded an MRR of 0.422, Hits@10 of 65.4%, and AUC-ROC of 0.847. External validation against the independent PREDICT dataset produced Hits@10 of 40%, confirming cross-dataset generalization. Case studies on Metformin and Hydroxychloroquine demonstrated the system across known associations, novel embedding-based predictions, and path-supported hypotheses with convergent biological evidence from pathway, transcriptomic, and chemical similarity analyses.

Conclusion

Knowledge graph embeddings, when integrated within structured biological validation, can produce drug repurposing hypotheses that are scientifically defensible and clinically contextualized. The multi-level evidence architecture transforms numerical predictions into testable scientific hypotheses suitable for guiding early-stage experimental investigation.

Zitieren

APA

Fuzail, M. M., Yahya, B. A., Iftekhar, S. S., & Khan, S. (2026). DrugRepur AI: An Explainable Knowledge Graph Embedding Platform for Drug Repurposing with Multi-Level Biological Validation. Journal of Innovations in Pharmaceutical and Biological Sciences, 13(01), 67-75. https://doi.org/10.56511/jipbs.2026.13108

Vancouver

Fuzail MM, Yahya BA, Iftekhar SS, Khan S. DrugRepur AI: An Explainable Knowledge Graph Embedding Platform for Drug Repurposing with Multi-Level Biological Validation. Journal of Innovations in Pharmaceutical and Biological Sciences. 2026;13(01):67-75. doi:10.56511/jipbs.2026.13108

BibTeX
@article{Fuzail2026,
  author = {Fuzail, Momin Mohammad and Yahya, Barrawaz Aateka and Iftekhar, Shaikh Shoaib and Khan, Sarfaraz},
  title = {DrugRepur AI: An Explainable Knowledge Graph Embedding Platform for Drug Repurposing with Multi-Level Biological Validation},
  journal = {Journal of Innovations in Pharmaceutical and Biological Sciences},
  year = {2026},
  volume = {13},
  number = {01},
  pages = {67--75},
  doi = {10.56511/jipbs.2026.13108}
}
Kostenlos starten →